CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 ...
Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting revenue and backlog. The AI precision medicine company grew core revenues 32% ...
Tempus AI Inc (NASDAQ:TEM) reported fourth-quarter financial results after the market close on Monday. Here’s a look at the key metrics from the quarter. Q4 Earnings: Tempus AI reported fourth-quarter ...
Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics of ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an ...
Tempus AI Inc TEM shares are trading higher Wednesday after the company announced a collaboration with Predicta Biosciences to commercially expand access to GenoPredicta, a co-branded whole-genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results